JARID2 and neoplasm: Analysis of a dataset of the International Cancer Genome Consortium (ICGC)/The Cancer Genome Atlas (TGCA) pan‐cancer whole genome analysis (n = 1210 samples, 23 tumor types) [26] (Table S5) revealed a negative correlation of JARID2 mRNA levels with those of HLA‐A and HLA‐C mRNAs (Fig. S4B–D).